Www1.actelion.com is a subdomain of actelion.com, which was created on 1998-01-15,making it 26 years ago.
Description:Our vision is to transform pulmonary hypertension (PH) into a long-term, manageable condition, so that patients can live a normal...
Keywords:Pulmonary hypertension,...
Discover www1.actelion.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 156.034 KB |
Page Load Time: 0.920557 Seconds |
Website IP Address: 104.18.35.49 |
NHCI National Hypertension Control Initiative - NHCI nhci.heart.org |
Chronic Obstructive Pulmonary Diseases | Journal of the COPD Foundation journal.copdfoundation.org |
PulmCCM Journal - An open access, peer reviewed journal in pulmonary and critical care medicinePulmC journal.pulmccm.org |
Leaders in Pulmonary & Critical Care Medicine - Division of Pulmonary & Critical Care Medicine pulmonary.wustl.edu |
Division of Nephrology, Hypertension & Renal Transplantation » College of Medicine » University of F nephrology.medicine.ufl.edu |
Hypertension | AHA/ASA Journals hyper.ahajournals.org |
Home page | BMC Pulmonary Medicine bmcpulmmed.biomedcentral.com |
Date: Tue, 14 May 2024 23:25:10 GMT |
Content-Type: text/html; charset=utf-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
expires: Wed, 15 May 2024 23:25:10 GMT |
Cache-Control: public, max-age=86400 |
content-security-policy: "default-src *; script-src * unsafe-eval self unsafe-inline https:; object-src self *.youtube.com youtube.com; style-src * self unsafe-inline; img-src * data:; media-src * blob:; frame-src *; frame-ancestors self; child-src self; font-src * data:; connect-src *; report-uri /report-csp-violation", x-content-security-policy: "default-src *; script-src * unsafe-eval self unsafe-inline https:; object-src self *.youtube.com youtube.com; style-src * self unsafe-inline; img-src * data:; media-src * blob:; frame-src *; frame-ancestors self; child-src self; font-src * data:; connect-src *; report-uri /report-csp-violation", x-webkit-csp: "default-src *; script-src * unsafe-eval self unsafe-inline https:; object-src self *.youtube.com youtube.com; style-src * self unsafe-inline; img-src * data:; media-src * blob:; frame-src *; frame-ancestors self; child-src self; font-src * data:; connect-src *; report-uri /report-csp-violation", x-xss-protection: 1; mode=block |
x-frame-options: SAMEORIGIN |
strict-transport-security: max-age=31536000; includeSubDomains |
referrer-policy: no-referrer-when-downgrade |
content-language: en |
x-content-type-options: nosniff |
permissions-policy: interest-cohort=() |
x-ua-compatible: IE=edge,chrome=IE8 |
x-generator: Drupal 7 (http://drupal.org) |
link: https://www.janssen.com/; rel="canonical" |
x-request-id: v-0118d67e-11bc-11ef-b013-a3a3bafdfcbf |
x-ah-environment: prod |
x-geo-country: |
vary: Accept-Encoding,X-Geo-Country |
Age: 60642 |
via: varnish |
x-cache: MISS |
CF-Cache-Status: HIT |
Last-Modified: Tue, 14 May 2024 06:34:28 GMT |
Server: cloudflare |
CF-RAY: 883ea55a2cc72ebb-LAX |
charset="utf-8"/ |
about="/article-type/pulmonary-hypertension" content="Pulmonary Hypertension" property="rdfs:label skos:prefLabel" typeof="skos:Concept"/ |
content="true" name="HandheldFriendly"/ |
content="width" name="MobileOptimized"/ |
content="on" http-equiv="cleartype"/ |
content="Our vision is to transform pulmonary hypertension (PH) into a long-term, manageable condition, so that patients can live a normal life." name="description"/ |
content="Pulmonary hypertension, patients" name="keywords"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
content="Drupal 7 (http://drupal.org)" name="generator"/ |
content="Janssen" property="og:site_name"/ |
content="article" property="og:type"/ |
content="https://www.janssen.com/pulmonary-hypertension" property="og:url"/ |
content="Pulmonary Hypertension" property="og:title"/ |
content="summary" name="twitter:card"/ |
content="https://www.janssen.com/pulmonary-hypertension" name="twitter:url"/ |
content="Pulmonary Hypertension" name="twitter:title"/ |
content="information" name="pagetype"/ |
content="telephone=no" name="format-detection"/ |
content="Janssen" name="apple-mobile-web-app-title"/ |
content="True" name="HandheldFriendly"/ |
content="320" name="MobileOptimized"/ |
content="width=device-width, initial-scale=1.0, user-scalable=no" name="viewport" |
http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" |
Janssen is now Johnson & Johnson Innovative Medicine Leading where medicine is going New identity. Same purpose. Discover more Janssen is now J&J Innovative Medicine. Learn more here | Visit JNJ.com MENU CLOSEJANSSEN GLOBAL CHANGE LOCATIONEnglish Español Français 日本語 Português (Brazil) Italiano 한국어 Русский Search Search Search Our Company AnnouncementCareers Contact Us Grants & Giving Leadership Blogs News Center Our Leaders Patient Safety Information Products Sustainability Transparency Our Focus Therapeutic Areas Cardiovascular, Metabolism & Retina Immunology Infectious Diseases & Vaccines Neuroscience Oncology Pulmonary Hypertension Patient Engagement Our Science Clinical Trials Compassionate Use & Pre-Approval Access R&D Data Science Janssen Global Trial Finder Research & Development World Without Disease Accelerator Partnerships Precision Medicine and Co-Diagnostics Unlocking the Power of Precision Medicine Careers We’re always seeking talented people who share our vision. Click here to explore opportunities in a variety of disciplines across the globe. See MoreLeadership Blogs Get to know our leaders. Read their unique perspectives on how they are working to change the trajectory of health. See MoreGeneration Care™ We’re committed to showing the heart of the caregiver’s experience and providing the kind of support and information that will make a difference. See MorePatient Engagement Janssen partners directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs. See MoreResearch & Development Our research pipeline is rich with transformational science reflecting our unique approach to innovation. See MoreR&D Data Science Using data science and digital health to reimagine the discovery and development of medicines to advance our mission of bringing transformative therapies to patients. See MoreCollaborating in more than 150 markets. By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com. These sections or websites are governed by their own Legal and Privacy Policies. Close Global Janssen Global English | Español Français | Nederlands |Português (BR) Italiano | 한국어 РУССКИЙ DEUTSCHAsia Pacific Asia Pacific (Regional) English Australia English China 中文 Hong Kong SAR, China English | 中文 India English Japan 日本 Korea 한국어 New Zealand English Europe, Middle East & Africa (EMEA) EMEA (Regional) English Austria Deutsch Belgium English | Français | Nederlands Bulgaria Български Croatia HRVATSKI Czech Republic Čeština Denmark Dansk Egypt EnglishEstonia English Finland Suomi France Français Germany Deutsch Greece ΕΛΛΗΝΙΚΑ Hungary Magyar Ireland English Israel עברית Italy Italiano Latvia English Lithuania English Netherlands Nederlands Norway Norsk Poland Polski Portugal Português Romania Română Russia Русский Serbia SRPSKI Slovakia SLOVENČINA Slovenia Slovenščina South Africa English Spain Español Sweden Svensk Switzerland Deutsch | Français Turkey Türkçe United Kingdom English Latin America Latin America (Regional) ESPAÑOL Argentina Español Bolivia Español Brazil Português Central America and the Caribbean Spanish | English Chile Español Colombia Español Ecuador EspañolEcuador Español Mexico Español Paraguay Español Peru Español Uruguay Español Venezuela EspañolNorth America Canada English | Français United States English Home › Pulmonary Hypertension Pulmonary Hypertension Our vision is to transform pulmonary hypertension (PH) into a long-term, manageable condition, so that patients can live a normal life. Read overview CapabilitiesDiscoveryDevelopmentCommercialization Focus Pulmonary Arterial Hypertension (PAH) Related Stories Five Things We Know about PAH Living with PAH With You Until PH Isn’t Partner with Us We are committed to partnering with those who share our vision to transform pulmonary hypertension into a long-term manageable condition. Learn More Leadership We work together to leverage scientific discovery and build on our knowledge to continue to support patients around the world. Learn more Related LinksOur Products Contact Pulmonary Hypertension Pulmonary Hypertension Pulmonary Hypertension Normal Artery in Cross Section (Magnification x100) H&E stainFind Janssen on: twitter youtube linkedin Find Janssen on: twitter youtube linkedin PRIVACY POLICY LEGAL NOTICE CONTACT US CAREERS NEWS CENTER janssen global © Janssen Global Services, LLC, 2012-2024. All Rights Reserved. Your use of information on this site is subject to the terms of our Legal Notice . Please see our Privacy Policy . This site is published by Janssen Global Services, LLC, which is solely responsible for its contents. Capitalized product names are trademarks of Johnson & Johnson or its affiliated companies. This information is intended for a global audience. Information specific to individual countries is identified where it appears. All third-party trademarks used herein are registered trademarks of their respective owners. This section of the global Janssen website provides a company overview in several languages. It is not targeted to any specific audience or country. Click here for country- and region-specific information of interest. Last Updated: May 14,...
Domain Name: ACTELION.COM Registry Domain ID: 2107591_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2023-12-13T15:01:02Z Creation Date: 1998-01-15T05:00:00Z Registry Expiry Date: 2025-01-14T05:00:00Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.JNJ.COM Name Server: NS3.JNJ.COM Name Server: NS5.JNJ.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:45:27Z <<<